Skip to site content
U.S. Department of Health and Human Services
National Pharmacy & Therapeutics Committee

Gallup Indian Medical Center Screening Eligibility Criteria for Early COVID-19 Therapy

Updated: 03/23/2022

  • Criteria are subject to change, please use the most up-to-date guidance from Dr. Gabrellas
  • All criteria must be met in order for a patient to be eligible
  • Further details on each agent can be found in the HCP EUA Fact Sheets for each agent

All agents are authorized for patients who are 65+ or who have at least one clinical condition that confers high risk for sequelae of COVID.

Underlying Conditions that Confer High Risk for Sequelae of COVID can be found on the CDC Underlying Conditions page Exit Disclaimer: You Are Leaving www.ihs.gov 

Therapies

  • Paxlovid oral therapy
    • Symptom onset within 5 days (onset date = day 0) with no new hypoxia
    • Evaluate for drug-drug interactions, Check Liverpool COVID-19 Drug Interaction Checker (Google it);
    • Check renal function and renally dose as follows:
      • eGFR >60 mL/min, no adjustment necessary
      • eGFR 30 to 60 mL/min, reduce to 150 mg nirmatrelvir and 100 mg ritonavir BID x5 days
    • Do not prescribe if:
      • Severe hepatic impairment (Child-Pugh Class C)
      • eGFR <30 mL/min or on dialysis
  • Short Course Remdesivir (200 mg on day one followed by 100 mg on days two and three, infused in 30-120 mins)
    • symptom onset within 7 days (onset date = day 0)
    • creatinine clearance >30ml/min in the past 7 days, if no labs available can get CMP and coags at first infusion visit (coags done at baseline due to uncommon SE of increase in PT)
    • commonly given to inpatients who have early COVID and are admitted for a non-COVID reason
  • Bebtelovimab infusion
    • Symptom onset within 7 days (onset date = day 0) with no new hypoxia
    • Only authorized for use in patients for whom no other FDA authorized therapy is appropriate or accessible

Important Phone Numbers

One Care Pharmacy: 505-726-4155 Fax: 505-726-4304

COVID Infusion RN: 505-979-1765

COVID Infusion Front Desk/Scheduler: 505-722-1553

Medical Records: 505-722-1116

COVID Therapeutics Phone (cell phone our team carries): 505-339-8898 

PHN Office: 505-722-1746

Hotel Isolation Referral: 505-231-8169

Occupational Health: 505-722-1381

COVID RN Hotline: 505-726-5888